AFP, published on Saturday, July 30, 2022 at 09:44
Tests for the detection of the monkeypox virus will be reimbursed 100% by Health Insurance, said Saturday an order in the Official Journal, after a recommendation to this effect from the High Health Authority.
“The development of the monkeypox epidemic implies being able to confirm cases of infection in the absence of a sufficiently explicit clinical picture” and nucleic acid amplification tests (NAAT) (a technique that includes PCR tests) “allow infections to be confirmed”, underlines this decree. “It is therefore appropriate that these screening tests be covered by Health Insurance”, continues the text.
Monday the High Authority for Health had decided for the reimbursement by Health Insurance of the tests, after having been seized by the Ministry of Health on the question.
The High Health Authority had recalled that the diagnosis is based first on the examination and questioning of the patient, specifying that “detection by NAAT test should only be carried out in the event of persistent doubt after clinical examination” for ” confirm or not” the infection.
“The use of this type of test is thus limited to + suspected cases + and + possible cases +, as defined by Public Health France and is not necessary in the absence of symptoms”, specified the health authority.